Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 Feb 6;13(2):303. doi: 10.3390/biom13020303

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2023 by the authors.

Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).

PMC Copyright notice

IHC analysis of cancer and paracancerous tissues in 172 patients confirms the CAV1 and CAV2 protein levels in HNSCC tissues, revealing that CAV1 and CAV2 are upregulated in HNSCC (a). The result shows a significant correlation is found for H-score in HNSCC and in OM cases after comparing the H-score, which represents the expression levels of target genes (p < 0.0001) ((b); mean ± SD: 6.21 ± 0.07; mean ± SD: 54.89 ± 2.36; mean ± SD: 9.72 ± 0.07; mean ± SD: 90.64 ± 95.81). Survival analysis shows a significant correlation between the low expression levels of CAV1 and CAV2 and longer survival days, indicating better prognostic performance (c).

IHC analysis of cancer and paracancerous tissues in 172 patients confirms the CAV1 and CAV2 protein levels in HNSCC tissues, revealing that CAV1 and CAV2 are upregulated in HNSCC (a). The result shows a significant correlation is found for H-score in HNSCC and in OM cases after comparing the H-score, which represents the expression levels of target genes (p < 0.0001) ((b); mean ± SD: 6.21 ± 0.07; mean ± SD: 54.89 ± 2.36; mean ± SD: 9.72 ± 0.07; mean ± SD: 90.64 ± 95.81). Survival analysis shows a significant correlation between the low expression levels of CAV1 and CAV2 and longer survival days, indicating better prognostic performance (c).